Ibere Pharmaceuticals Stock Price, News & Analysis
IBER
NYSE
Company Description
Ibere Pharmaceuticals (NYSE: IBER) is a publicly traded company.
IBER stock has gained 4.4% over the past year.
This page provides a comprehensive overview of IBER stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
$—
0.00%
0.00
Last updated:
+4.41%
Performance 1 year
$0.0
17.3M
Ibere Pharmaceuticals (IBER) stock. Over the past 12 months, the stock has gained 4.4%.
Latest News
Ibere Pharmaceuticals has 3 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. Key topics include IPO, offering. View all IBER news →
SEC Filings
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Operating Cash Flow
Upcoming Events
Short Interest History
Last 12 Months
Days to Cover History
Last 12 Months